MedPath
HSA Approval

SODIUM CHLORIDE 0.9% SOLUTION FOR INTRAVENOUS INFUSION

SIN13052P

SODIUM CHLORIDE 0.9% SOLUTION FOR INTRAVENOUS INFUSION

SODIUM CHLORIDE 0.9% SOLUTION FOR INTRAVENOUS INFUSION

March 4, 2005

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

INTRAVENOUS

Medical Information

B05XA03

sodium chloride

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

BIEFFE MEDITAL S.A.

Baxter Healthcare Limited

Active Ingredients

SODIUM CHLORIDE

0.9g/100ml

Sodium chloride

Documents

Patient Information Leaflets

Baxter Sodium Chloride Infusion_PIL.pdf

Approved: September 13, 2021

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SODIUM CHLORIDE 0.9% SOLUTION FOR INTRAVENOUS INFUSION - HSA Approval | MedPath